1 January 2025 false No description of principal activity Taxfiler 2024.6 13819181 business:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 13819181 2024-12-31 13819181 2025-01-01 2025-12-31 13819181 business:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 13819181 business:FilletedAccounts 2025-01-01 2025-12-31 13819181 2025-12-31 13819181 2024-12-31 13819181 core:WithinOneYear 2025-12-31 13819181 core:WithinOneYear 2024-12-31 13819181 core:ShareCapital core:PreviouslyStatedAmount 2025-12-31 13819181 core:ShareCapital core:PreviouslyStatedAmount 2024-12-31 13819181 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-12-31 13819181 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-12-31 13819181 core:PreviouslyStatedAmount 2025-12-31 13819181 core:PreviouslyStatedAmount 2024-12-31 13819181 business:SmallEntities 2025-01-01 2025-12-31 13819181 business:Director1 2025-01-01 2025-12-31 13819181 countries:EnglandWales 2025-01-01 2025-12-31 13819181 business:RegisteredOffice 2025-01-01 2025-12-31 13819181 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure
Company Registration No. 13819181 (England and Wales)
Eramol Therapeutics Limited Unaudited accounts for the year ended 31 December 2025
Eramol Therapeutics Limited Unaudited accounts Contents
Page
Statement of financial position
3
Notes to the accounts
4
- 2 -
Eramol Therapeutics Limited Statement of financial position as at 31 December 2025
2025
2024
Notes
£
£
Current assets
Debtors
4
316,073
247,274
Cash at bank and in hand
27,692
6,593
343,765
253,867
Creditors: amounts falling due within one year
5
(142,547)
(51,863)
Net current assets
201,218
202,004
Net assets
201,218
202,004
Capital and reserves
Called up share capital
1
1
Profit and loss account
201,217
202,003
Shareholders' funds
201,218
202,004
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 3 March 2026 and were signed on its behalf by
Ka Yan Che Director Company Registration No. 13819181
- 3 -
Eramol Therapeutics Limited Notes to the Accounts for the year ended 31 December 2025
1
Statutory information
Eramol Therapeutics Limited is a private company, limited by shares, registered in England and Wales, registration number 13819181. The registered office is Unit 9 North Downs Business Park, Limepit Lane, Sevenoaks, TN13 2TL, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Debtors
2025
2024
£
£
Amounts falling due within one year
Amounts due from group undertakings etc.
1
1
Other debtors
316,072
247,273
316,073
247,274
5
Creditors: amounts falling due within one year
2025
2024
£
£
Amounts owed to group undertakings and other participating interests
51,247
51,213
Loans from directors
90,000
-
Accruals
1,300
650
142,547
51,863
6
Transactions with related parties
Related Party Transactions As at 31 December 2025, £51,247 (2024: £51,213) remains owed to Eramol (UK) Ltd as a loan. This transaction has been disclosed in accordance with the requirements of FRS 102 Section 33 and company law relating to related party transactions.
7
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 4 -